v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenue $ 101,630 $ 700,433
Cost of revenue 55,798 511,433
Gross profit 45,832 189,000
Operating expenses    
Selling, general, and administrative 1,674,206 3,736,450
Research and development 24,455 48,964
Impairment of ENTADFI 2,293,576
Impairment of goodwill 10,918,000 5,192,000
Total operating expenses 12,616,661 11,270,990
Loss from operations (12,570,829) (11,081,990)
Other (expense) income    
Interest expense - related party (225,063)
Interest expense (223,592) (187,993)
Change in fair value of subscription agreement liability – related party 3,319,000 226,400
Change in fair value of contingent warrant liabilities (9,795)
Gain on forgiveness of accounts payable 944,694
Other income (loss) (5,363) 28,507
Total other income (loss) 4,024,944 (158,149)
Loss before income taxes (8,545,885) (11,240,139)
Income tax benefit 121,567
Net loss (8,545,885) (11,118,572)
Deemed dividend Series C preferred stock (1,170,091)
Net loss applicable to common stockholders $ (9,715,976) $ (11,118,572)
Net loss per share, basic (in Dollars per share) $ (0.53) $ (20.08)
Net loss per share, diluted (in Dollars per share) $ (0.53) $ (20.08)
Weighted average number of common shares outstanding, basic (in Shares) 18,176,261 553,690
Weighted average number of common shares outstanding, diluted (in Shares) 18,176,261 553,690
Other comprehensive income (loss)    
Net loss $ (8,545,885) $ (11,118,572)
Foreign currency translation 141,048 (4,991,144)
Change in pension benefit obligation (30,779) 154,678
Total comprehensive loss $ (8,435,616) $ (15,955,038)